Article
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
The New England journal of medicine - 1 May 2008
Schlenk Richard F, Döhner Konstanze, Krauter Jürgen, Fröhling Stefan, Corbacioglu Andrea, Bullinger Lars, Habdank Marianne, Späth Daniela, Morgan Michael, Benner Axel, Schlegelberger Brigitte, Heil Gerhard, Ganser Arnold, Döhner Hartmut
Abstract excerpt
BACKGROUND: Mutations occur in several genes in cytogenetically normal acute myeloid leukemia (AML) cells: the nucleophosmin gene (NPM1), the fms-related tyrosine kinase 3 gene (FLT3), the CCAAT/enhancer binding protein alpha gene (CEPBA), the myeloid-lymphoid or mixed-lineage leukemia gene (MLL), and the neuroblastoma RAS viral oncogene homolog (NRAS). We evaluated the associations of these mutations with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
